Atypical teratoid rhabdoid tumor other diagnostic studies: Difference between revisions
(→Biopsy) |
|||
Line 10: | Line 10: | ||
===Fluorescent In Situ Hybridization=== | ===Fluorescent In Situ Hybridization=== | ||
*Fluorescence in situ hybridization demonstrates abnormalities of [[22q11.2 deletion syndrome|chromosome 22q11.2]]. | |||
===Bone Marrow Aspiration=== | ===Bone Marrow Aspiration=== |
Revision as of 21:03, 16 December 2015
Atypical teratoid rhabdoid tumor Microchapters |
Differentiating Atypical Teratoid Rhabdoid Tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Atypical teratoid rhabdoid tumor other diagnostic studies On the Web |
American Roentgen Ray Society Images of Atypical teratoid rhabdoid tumor other diagnostic studies |
FDA on Atypical teratoid rhabdoid tumor other diagnostic studies |
CDC on Atypical teratoid rhabdoid tumor other diagnostic studies |
Atypical teratoid rhabdoid tumor other diagnostic studies in the news |
Blogs on Atypical teratoid rhabdoid tumor other diagnostic studies |
Directions to Hospitals Treating Atypical teratoid rhabdoid tumor |
Risk calculators and risk factors for Atypical teratoid rhabdoid tumor other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Other Diagnostic Studies
Biopsy
Biopsy is performed for definitive diagnosis of atypical teratoid rhabdoid tumor.[1]
Fluorescent In Situ Hybridization
- Fluorescence in situ hybridization demonstrates abnormalities of chromosome 22q11.2.
Bone Marrow Aspiration
(Bone Marrow Asperant) to check for bone tumors. Often a doctor will want perform a stem cell transplant
References
- ↑ Diagnostic evaluation of atypical teratoid rhabdoid tumor. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq#link/_113_toc. Accessed on December 16, 2015